Similar Stories to Is Viking Therapeutics The Best Nash Stock To Buy Now? on Bing News

newsfeedback@fool.com (Cory Renauer), The Motley Fool
Thu, 09/20/2018 - 5:48am

Shares of Viking Therapeutics (NASDAQ: VKTX) soared after the biotech announced solid results for its lead candidate. That's because it's aimed at treating non-alcoholic steatohepatitis (NASH), or liver damage caused by excess fat buildup. NASH threatens the lives of around 20 million Americans, and there aren't any effective treatment options yet.Viking Therapeutics probably won't be the first biotech to market a NASH treatment, but it looks like its lead candidate could be best at stopping NASH from occurring in the first place. Let's look at what results for VK2809 could mean for Viking shareholders down the road to see if this is the best NASH stock investors can buy right now.Image source: Getty Images.Continue reading

PREV NEXT
Topics:  viking therapeutics nasdaq   vktx    americans   vk2809   images   viking therapeutics   viking   nash   buy   results   treatment   candidate   lead   biotech   
BING NEWS:
  • Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
    Viking Therapeutics has a good ... Madrigal's claim to being the better biotech stock is its drug Rezdiffra, which is the first medicine approved to treat metabolic-associated steatohepatitis, (MASH, ...
    06/9/2024 - 10:45 pm | View Link
  • This High-Flying Stock Just Announced More Good News: Time to Buy?
    The stock has more than tripled since early ... Up until just a couple of months ago, there were no approved therapies for NASH. There remains a significant unmet need here, one which Viking ...
    06/8/2024 - 9:45 pm | View Link
  • Structure Therapeutics vs. Viking Therapeutics: Which Weight-Loss Drug Stock Wins?
    Charting, Price Performance, News & Related Contracts.
    06/6/2024 - 6:58 am | View Link
  • Buy Rating on Viking Therapeutics: Promising NASH Treatment and Strategic Partnerships Drive Positive Outlook
    Naz Rahman, an analyst from Maxim Group, maintained the Buy rating on Viking Therapeutics (VKTX – Research Report). The associated price ...
    06/5/2024 - 5:55 am | View Link
  • Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
    Viking Therapeutics stock crumbled Tuesday despite seemingly positive test results for a drug that treats a serious liver disease.Please watch the video at Investors.com - Glitches, Elections And ...
    06/4/2024 - 9:19 am | View Link
  • More
PREV NEXT

 

PREV NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News